Bruker Daltonics Scientific Posters
Discover new ways to apply mass spectrometry to today’s most pressing analytical challenges. Innovations such as Trapped Ion Mobility (TIMS), smartbeam and scanning lasers for MALDI-MS Imaging that deliver true pixel fidelity, and eXtreme Resolution FTMS (XR) technology capable to reveal Isotopic Fine Structure (IFS) signatures are pushing scientific exploration to new heights. Our mass spectrometry solutions enable scientists to make breakthrough discoveries and gain deeper insights.
Our industry leading software solutions such as SCiLs Lab for MS Imaging, ProteinScape® for Proteomics and Glycomics, MetaboScape® for Metabolomics, TASQ® for Screeing Quantitation, Biopharma Compass 2.0, and Toxtyper are examples our solutions doing the work for you.
Bruker's product lines include the following technologies: MRMS (FTMS), rapifleX MALDI-TOF/TOF, ESI QTOF, timsTOF/ Pro, UHPLC, Toxtyper, Triple Quadrupole, HDX Solution, TargetScreener HR
Ulrike Schweiger-Hufnagel1, Aiko Barsch1, Sven W. Meyer1
1Bruker Daltonik GmbH, 28359 Bremen, Germany
Matt Willetts1, Shourjo Ghose1 Heiner Koch2, Scarlet Koch2, Markus Lubeck2, Gary Kruppa1
1Bruker Daltonics, Billerica, MA, USA 2Bruker Daltonik GmbH, 28359 Bremen, Germany
Sebastian Götz1, Sven W Meyer1,Ulrike Schweiger-Hufnagel1,Aiko Barsch1, Ningombam Sanjib Meitei2
1Bruker, Bremen, Germany 2PREMIER Biosoft, Indore, India
Markus Lubeck(1), Heiner Koch(1), Scarlet Beck(1), Paul Savage(2), Oliver Raether(1), Pierre-Olivier Schmit(2) Paul Shan (3) and Gary Kruppa (4)
(1) Bruker Daltoniks GmbH, Bremen-Germany, (2) Bruker France SA, Wissembourg, France, (3) Bioinformatics Solutions, Waterloo, Canada, (4) Bruker Daltonics Inc, Billerica, USA
Takashi Nirasawa1, Megumi Terada2,3, Hiroko Namba2, Nobuto Kakuda2, Patrick Bruneval3, Hatsue Ishibashi-Ueda4 and Masaya Ikegawa1
1.Bruker Japan, K.K., Yokohama, Japan 2.Doshisha University, Faculty of Life and Medical Systems, Kyoto, Japan 3.Georges-Pombidou European Hospital, Anatomy-Pathology, Paris, France 4.National Cerebral and Cardiovascular Research Center, Osaka, Japan
Nobuto Kakuda1, Tomohiro Miyasaka1, Takashi Nirasawa2, Shigeo Murayama3, Yasuo Ihara1 and Masaya Ikegawa1
1.Doshisha University, Faculty of Life and Medical Systems, Kyoto, Japan 2.Bruker Japan, K.K., Yokohama, Japan 3.The Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital, Itabashi, Japan